Horlock Phil

Director Phil Horlock sells 42,258 shares of BLBD for $2,437,018.86 across two transactions at $57.18 and $58.16.

Phil Horlock, a director of Blue Bird Corp (BLBD), executed two separate sales totaling 42,258 shares for $2,437,018.86 on August 15 and August 18, 2025, reducing his holdings by 14.9% from 283,024 to 240,766 shares. The sales occurred near the 52-week high of $58.50, with the blended average price of $57.67 placing them within 1.4% of the peak, despite the stock's 33.4% surge over the prior 30 days and 45.5% over 90 days. Horlock's prior four measurable sales at BLBD all realized negative 90-day returns (ranging from -14.0% to -15.8%), establishing a pattern of well-timed exits at this ticker; this current sale at near-peak valuations aligns with that historical pattern. The company's fundamentals remain solid (18.9% annual revenue growth, P/E of 15.63, net income of $36,455,000.00), but the timing of the sale after sustained price appreciation and near the 52-week high warrants investor attention to whether the director's actions reflect view of valuation or simply portfolio rebalancing at an inflection point.

Director Phil Horlock sold 30,000 shares of BLBD at $60.00 for $1,800,000; stock now $54.69 as 90d return climbs +34.7%

Horlock sold 30,000 shares (11.1% of pre-transaction holdings) at $60.00 on 2025-08-08, reducing his stake to 240,766 shares. At $54.69 current price, the transaction price sits 1.2% below the 52-week high of $55.34. Over the 90 days following prior sells at BLBD, Horlock achieved a 90-day well-timed rate of 4 of 5 (80% positive timing at the 90-day mark), meaning his previous exits preceded stock declines. However, BLBD's fundamentals remain sound: $398.0M revenue, $36.5M net income, +18.9% annual revenue growth, and a P/E of 14.98, with the stock up +34.7% over 90 days and +21.7% over 30 days. The sale occurred near but not at the recent peak; whether this distribution of 11.1% of holdings reflects a systematic pattern or a discrete rebalancing event requires further monitoring given the company's positive growth trajectory.

CEO Phil Horlock sells 59,752 shares (59.8K) at blended $50.00, reducing stake by 16.6%

Phil Horlock, Chief Executive Officer of Blue Bird Corp, executed 2 separate sales on 2024-09-13 and 2024-09-16, totaling 59,752 shares (59.8K shares) for $2,987,331.20 ($3.0M) at a blended average price of $50.00. This reduces his post-transaction holdings to 299,812 shares (299.8K shares) from a pre-transaction level of 359,564 shares (359.6K shares). The sales occurred at prices near current levels ($50.19 current price; stock is -13.3% from 52-week high but +4.7% over 30 days). His prior trades at BLBD show a 0 of 3 well-timed rate on sells measured at 90 days—recent sales on 2024-08-26 and 2024-08-23 remain unmeasurable. Against his cross-ticker track record of a 0.00% well-timed rate across 8 prior sells, this sale adds incremental data but does not establish a pattern of prescient timing. The company reports strong fundamentals: annual revenue growth of +41.5%, net income of $28,711,000.00 ($28.7M), and a P/E of 16.30.

CEO Horlock sells 48,239 BLBD shares for $2.3M across two transactions; post-sale holdings at 299.8K shares (-13.9%).

Horlock Phil, Chief Executive Officer of Blue Bird Corp, executed two separate open-market sales totaling 48,239 shares for $2,334,767.07 on 2024-08-23 and 2024-08-26, reducing his holdings by 13.9% from 348,051 to 299,812 shares. The sales occurred at a blended average price of $48.40, near the current price of $49.60 and within the 52-week range ($17.79–$57.87). Notably, his prior five sales at BLBD have consistently underperformed on a 90-day basis—0 of 5 were well-timed (stock rose after each sale), with average 90-day returns of +60.6%, +13.8%, +5.9%, +17.1%, and +33.4%—suggesting the insider has not historically executed sales ahead of price declines at this ticker. Against the backdrop of strong fundamentals (annual revenue growth of +41.5%, net income of $28.7M on revenue of $333.4M, P/E of 16.10), this sale represents a material reduction in direct insider equity exposure rather than a signal of operational concern.